Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating ...

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

Parikh is backed up by experienced CRO leader William Gannon Jr., M.D., who is LyfeSci’s chief medical officer. Gannon has ...

Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.

AI in pharmaceuticals spans blue-sky possibilities to immediate practical applications delivering value today. AI-powered ...

Introduction: Inequalities in access to clinical trials in cancer, haematology and rare diseases, along with the inconsistent incorporation and reporting of patient reported outcome measures (PROMs) ...

Harpreet Singh, MD, former director of the FDA's Division of Oncology 2 and chief medical officer of Precision for Medicine, discusses the FDA's draft guidance on the use of overall survival (OS) as ...

Two clinical trials of Merck’s pulmonary arterial hypertension (PAH) drug Winrevair were so conclusive that the studies were halted within the last year because the efficacy of the treatment was ...

James is a pulmonary and critical care physician specializing in sarcoidosis. When one of my patients was first diagnosed with sarcoidosis, her specialist gave her two options: take steroids or join a ...

Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...